Aspirus Selects MedQuist Clinical Documentation Technology Solution for Network-Wide Productivity Improvement, EHR Adoption a...
June 24 2011 - 9:00AM
MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of
integrated clinical documentation solutions for the U.S. healthcare
system, today announced that it has been awarded a contract by
Aspirus Inc., of Wausau, Wisconsin, for clinical documentation
technology. The offering includes mobility enabled solutions,
digital voice capture, a speech recognition and document workflow
platform, voice-enabled EHR functionality and transcription
services.
In preparation for Computerized Physician Order Entry (CPOE),
the Aspirus team needed to replace their aging voice capture and
transcription platform, according to Jerry Mourey, chief
information officer (CIO) for Aspirus. In addition, Aspirus HIM
leaders wanted leading-edge speech recognition technology to help
them improve productivity of their in-house transcriptionists while
boosting physician adoption and usability of their EHR. Cost
reduction and improved reimbursements were also goals of the
organization.
"We considered an upgrade based on our longstanding
relationship, our deep functional and technical knowledge and a
limited amount of time and resources for exploring other options –
until we discovered the exceptional portfolio of MedQuist solutions
and the team that stands behind them," Mourey added. "Making time
for due diligence, we realized MedQuist could do more for us in
terms of technology, customer care and meeting outcomes to support
our needs, goals and objectives."
After a six-month evaluation period, Aspirus selected MedQuist
and its DocQment™ EP platform. Aspirus' EHR training team was also
impressed by the five-minute installation and simple support
features for DocQment Direct, which provides EHR speech recognition
capabilities.
"MedQuist proved – even to our most hesitant clinicians – that
upgrading to a robust enterprise technology platform would not only
be seamless for them, but that they will realize significant time
savings from user-friendly tools that streamline workflow, deliver
highly accurate speech recognition that follows physicians wherever
they go and interface beautifully," said Dr. Larry Gordon, D.O.,
Medical Director of Informatics."Whether we want to document with a
smart phone, dictate straight into the EHR or edit our own reports
in a real-time, interactive environment, MedQuist has the
technology and the know-how to make it a reality and make our jobs
easier."
MedQuist speech recognition and workflow platforms are designed
to increase MT productivity and facilitate impressive turnaround
time improvements. With MedQuist, Aspirus plans to complete
critical ED work more quickly, reduce discharge summaries from 72
hours to less than 24 hours, and reduce cardiology reports from 24
hours to less than 12 hours. "Faster report turnaround times (TATs)
speed coding, billing and patient movement – enabling rapid care
delivery for patients and a healthier revenue cycle for the
hospital," said Jeanne Scinto, PhD, MPH, vice president Corporate
Quality Services for Aspirus.
"Improved efficiency and productivity is just the beginning of
the ROI we will experience by implementing MedQuist technology.
MedQuist also offered a better way for us to manage our capital
dollars by moving from enterprise licenses to transactional
licenses. Their cloud-based technology minimizes maintenance costs,
and integration with our EHR and billing systems means better
reimbursements," said Chris Plaisance, director of IT Solutions for
Aspirus. "We will realize immediate cost reduction benefits, and
over the next five years we expect to see savings of $6 million or
more."
MedQuist's industry-specific expertise, genuine understanding of
Aspirus' unique needs and challenges, and ability to demonstrate
success, long-term support and exceptional reliability led to the
partnership, according to Peter Masanotti, president and chief
executive officer (CEO) of MedQuist. "We are honored to be selected
by Aspirus as their partner of choice," he said.
About MedQuist
MedQuist is a leading provider of medical transcription services
and a leader in technology-enabled clinical documentation workflow.
MedQuist's enterprise solutions – including mobile voice capture
devices, speech recognition, Web-based workflow platforms, and
global network of medical editors – help healthcare facilities
improve patient care, increase physician satisfaction, and lower
operational costs. For more information, please visit
www.medquist.com.
About Aspirus
Aspirus is a non-profit, community-directed health system based
in Wausau. With more than 5,500 employees, Aspirus serves people in
14 Wisconsin counties and the Upper Peninsula of Michigan through a
series of affiliated hospitals; home health care; pharmacies;
hospice care; critical care and helicopter transport service; a
durable medical goods company; a nursing home; a large volunteer
corps; an affiliated physician network; a philanthropic and
research foundation; and an extensive clinics network.
"Safe Harbor" Statement under the U.S. Private Securities
Litigation Reform Act of 1995: Statements in this press release
regarding MedQuist's business that are not historical facts are
"forward-looking statements" that involve risks and uncertainties.
Actual outcomes and results may differ materially from what is
expressed or forecasted in forward-looking statements. As a result,
forward-looking statements speak only as of the date they were
made, and the Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
CONTACT: Thomas Mitchell
Director of Marketing
615-798-6630
tmitchell@medquist.com
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024